Answer
Flecainide acetate markedly inhibits cardiac fast sodium channels with slow onset and offset, slowing conduction and potentially prolonging PR and QRS intervals; it leaves ventricular muscle action-potential duration unchanged but markedly shortens it in Purkinje fibres, with a modest increase in effective refractory period in isolated cardiac tissues.
Sources for this answer
- Flecainide Acetate 100 mg tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked